Ben Kennedy

Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival

Paul Moreton, Ben Kennedy, Guy Lucas et al. · Journal of Clinical Oncology · 2005 · 421 citations

Medicine, Hematology, Oncology +16

Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts

Andy C. Rawstron, Michael J. Green, Anita Kuzmicki et al. · Blood · 2002 · 335 citations

Medicine, Hematology, Oncology +10

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

Andy C. Rawstron, Ben Kennedy, Paul Evans et al. · Blood · 2001 · 267 citations · Full text

Medicine, Hematology, Oncology +15

Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion

Andy C. Rawstron, Martin Yuille, Julie Fuller et al. · Blood · 2002 · 223 citations · Full text

Life Sciences, Hematology, Immunology +12

Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia

Ben Kennedy, Andy C. Rawstron, Mary Ryan et al. · Blood · 2002 · 190 citations · Full text

Medicine, Oncology, Pharmacology +12